An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.
- Submitting institution
-
The University of Liverpool
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 7795
- Type
- D - Journal article
- DOI
-
10.1038/ncb2953
- Title of journal
- Nature Cell Biology
- Article number
- -
- First page
- 457
- Volume
- 16
- Issue
- 5
- ISSN
- 1465-7392
- Open access status
- Out of scope for open access requirements
- Month of publication
- April
- Year of publication
- 2014
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
19
- Research group(s)
-
A - Cancer Medicine
- Citation count
- 213
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- AM made a substantial contribution to:
The concept and design of the study.
AM also contributed to the intellectual critique and approval of the manuscript.
- Non-English
- No
- English abstract
- -
